And having people be healthier in terms of their eating, and it's not, you know, heavy people aren't at fault, right
In a recent clinical trial of this new drug, 58% of participants taking the competitors drug experienced mild-to-moderate side effects, and about 10% stopped the medication because of side effects
A) Once-daily long-acting insulin glargine (typically given at bedtime) achieves a steady-state within ~2 hours, does not display a distinct peak, and has a 20-24 hour duration of action in most patients
Emerging drugs for primary progressive multiple sclerosis
Schafer AL, Kazakia GJ, Vittinghoff E, Stewart L, Rogers SJ, Kim TY, et al